Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Jennifer L. Crombie"'
Autor:
Fen Zhu, Jennifer L. Crombie, Wei Ni, Nguyet-Minh Hoang, Swati Garg, Liam Hackett, Stephen J. F. Chong, Mary C. Collins, Lixin Rui, James Griffin, Matthew S. Davids
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Despite recent advances in the therapy of diffuse large B-cell lymphoma (DLBCL), many patients are still not cured. Therefore, new therapeutic strategies are needed. The anti-apoptotic B-cell lymphoma 2 (BCL2) gene is commonly dysregulated in DLBCL d
Externí odkaz:
https://doaj.org/article/8b0191ebd1284f62ab563c4cfef6f73e
Autor:
Jennifer L. Crombie, Caron A. Jacobson, Robert Redd, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Jordan Gauthier, Erin Mullane, Kirk Cahill, Justin Kline, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Philippe Armand, Brian Hess
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5acdfcb9d33441d58498adc67547a25c
Autor:
Jennifer L. Crombie, Ann S. LaCasce
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population. EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though subsequently has been found to drive a variety of malignancies, includ
Externí odkaz:
https://doaj.org/article/0653d0b370e44b75a375345c4551f0e4
Autor:
David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Publikováno v:
Blood. 140:787-789
Autor:
Reid W Merryman, Robert A. Redd, Arnold S. Freedman, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D Jacobsen, Austin I. Kim, Ann S. LaCasce, Samuel Ng, Oreofe O. Odejide, Erin Michelle Parry, Iris Isufi, Justin Kline, Jonathon B. Cohen, Neha Mehta-Shah, Nancy L. Bartlett, Matthew Mei, Philippe Armand, Caron A. Jacobson
Publikováno v:
Blood. 140:6531-6533
Autor:
Alex F. Herrera, Lu Chen, Jennifer L. Crombie, Jonathon B. Cohen, Ranjana H. Advani, Ann S. LaCasce, Leslie L. Popplewell, Sandrine Puverel, Lacolle Peters, Shari Daniels, James Godfrey, Geoffrey Shouse, Matthew Mei, Swetha Kambhampati, L. Elizabeth Budde, Liana Nikolaenko, Steven T. Rosen, Larry W. Kwak, Stephen J Forman, Matthew J. Matasar
Publikováno v:
Blood. 140:1065-1067
Autor:
Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Susan M O'Brien, Julio C Chávez, Johannes Duell, Andreas Rosenwald, Jennifer L Crombie, Melanie Ufkin, Jingjin Li, Min Zhu, Srikanth R Ambati, Aafia Chaudhry, Israel Lowy, Max S Topp
Publikováno v:
The Lancet Haematology. 9:e327-e339
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells. We aimed to evaluate the safety and antitumour activity of odronextamab in patients with relapsed or refractory
Autor:
Austin I. Kim, Caron A. Jacobson, Zixu Wang, Ann S. LaCasce, Samantha Pazienza, Jessica Lowney, Jennifer R. Brown, Matthew S. Davids, Jennifer L. Crombie, Matthew Weinstock, David C. Fisher, Svitlana Tyekucheva, Jon E. Arnason, Philippe Armand, Josie Montegaard, Samuel Y. Ng, Benjamin L. Lampson, Victoria Patterson
Publikováno v:
The Lancet Oncology. 22:1391-1402
Both continuous therapy with acalabrutinib and fixed-duration therapy with venetoclax-obinutuzumab are effective for previously untreated chronic lymphocytic leukaemia. We hypothesised that frontline time-limited, minimal residual disease (MRD)-guide
Autor:
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Kristin M McHugh, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Eric D. Jacobsen, Caron A. Jacobson, Austin I Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O Odejide, Erin M. Parry, Heather Jacene, Hyesun Park, Parastoo B. Dahi, Yago Nieto, Robin Joyce, Yi-Bin Chen, Margaret A. Shipp, Alex F. Herrera, Philippe Armand
Publikováno v:
Blood Advances.
Improved biomarkers are needed to guide the optimal use of autologous stem cell transplantation (ASCT) for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). We hypothesized that minimal residual disease (MRD) identified u
Autor:
Eleanor Taranto, Robert Redd, Erin Jeter, Kristin McHugh, Jennifer L. Crombie, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Oreofe O. Odejide, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi-Bin Chen, Kimberley-Jane C. Bonjoc, Ammar Chaudhry, Alex F. Herrera, Philippe Armand, Reid W. Merryman
Publikováno v:
Leukemialymphoma. 63(12)
Improved biomarkers are needed to guide patient selection for autologous stem cell transplantation (ASCT) and post-ASCT maintenance therapies in relapsed/refractory classical Hodgkin lymphoma (cHL). To assess the prognostic value of minimal residual